Skip to main content
. Author manuscript; available in PMC: 2016 May 1.
Published in final edited form as: Pediatr Blood Cancer. 2014 Oct 12;62(5):743–750. doi: 10.1002/pbc.25269

Figure 2.

Figure 2

NTX-010 Clearance: 2A) NTX-010 serum clearance from Part A of the study; 2B) NTX-010 serum clearance from Part B of the study; Patients 14 and 17 received a single dose of NTX-010 whereas patients 15 and 18-22 received 2 doses of NTX-010 2C) NTX-010 stool clearance from Part A of the study; 2D) NTX-010 stool clearance from Part B of the study; Patients 14 and 17 received a single dose of NTX-010 whereas patients 15 and 18-22 received 2 doses of NTX-010.